These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29869153)

  • 1. [Current patient care of giant cell arteritis in Rhineland-Palatinate].
    von Kiel C; Dreher M; Triantafyllias K; Heinz P; Schwarting A
    Z Rheumatol; 2019 Sep; 78(7):677-684. PubMed ID: 29869153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
    Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH
    Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Our approach to the diagnosis and treatment of polymyalgia rheumatica and giant cell (temporal) arteritis.
    Quick V; Kirwan JR
    J R Coll Physicians Edinb; 2012; 42(4):341-9. PubMed ID: 23240123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polymyalgia rheumatica and giant cell arteritis: recent data and current situation].
    Announ N; Guerne PA
    Rev Med Suisse; 2008 Mar; 4(149):696-8, 701. PubMed ID: 18472729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates in the Diagnosis and Management of Giant Cell Arteritis.
    Uppal S; Hadi M; Chhaya S
    Curr Neurol Neurosci Rep; 2019 Aug; 19(9):68. PubMed ID: 31396718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of polymyalgia rheumatica and large vessel vasculitis].
    Hellmich B
    Internist (Berl); 2016 Nov; 57(11):1069-1078. PubMed ID: 27631531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
    Matteson EL; Buttgereit F; Dejaco C; Dasgupta B
    Rheum Dis Clin North Am; 2016 Feb; 42(1):75-90, viii. PubMed ID: 26611552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant cell arteritis and polymyalgia rheumatica: an update.
    González-Gay MA; Pina T
    Curr Rheumatol Rep; 2015 Feb; 17(2):6. PubMed ID: 25618572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Headache Federation recommendations for neurologists managing giant cell arteritis.
    Mollan SP; Paemeleire K; Versijpt J; Luqmani R; Sinclair AJ
    J Headache Pain; 2020 Mar; 21(1):28. PubMed ID: 32183689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myalgias and Myopathies: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Mansalis K
    FP Essent; 2016 Jan; 440():16-22. PubMed ID: 26734832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis and classification of giant cell arteritis.
    Nesher G
    J Autoimmun; 2014; 48-49():73-5. PubMed ID: 24461386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
    Lally L; Spiera R
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
    Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C
    BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis.
    Ehlers L; Askling J; Bijlsma HW; Cid MC; Cutolo M; Dasgupta B; Dejaco C; Dixon WG; Feltelius N; Finckh A; Gilbert K; Mackie SL; Mahr A; Matteson EL; Neill L; Salvarani C; Schmidt WA; Strangfeld A; van Vollenhoven RF; Buttgereit F
    Ann Rheum Dis; 2019 Sep; 78(9):1160-1166. PubMed ID: 30898837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyalgia rheumatica and giant cell arteritis.
    Unwin B; Williams CM; Gilliland W
    Am Fam Physician; 2006 Nov; 74(9):1547-54. PubMed ID: 17111894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polymyalgia rheumatica and temporal arteritis].
    Vos PA; Bijlsma JW; Derksen RH
    Ned Tijdschr Geneeskd; 2005 Aug; 149(35):1932-7. PubMed ID: 16159030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyalgia rheumatica: 125 years of progress?
    Rooney PJ; Rooney J; Balint G; Balint P
    Scott Med J; 2014 Nov; 59(4):220-8. PubMed ID: 25201885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of diagnosis and management of giant cell arteritis in general practice: a multimethods study.
    Helliwell T; Muller S; Hider SL; Prior JA; Richardson JC; Mallen CD
    BMJ Open; 2018 Feb; 8(2):e019320. PubMed ID: 29431135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.